{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:21:26Z","timestamp":1759335686019,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["OL 605\/1-1"],"award-info":[{"award-number":["OL 605\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract\n<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To study the association between timing and success of electrical cardioversion (ECV) for the treatment of early recurrences (ERs) of atrial fibrillation post pulmonary vein isolation (PVI) on long-term rhythm outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data of 133 patients ablated for paroxysmal or persistent atrial fibrillation receiving ECV for ERs, i.e., atrial tachyarrhythmia recurrences within 90\u00a0days post ablation were analyzed. During 1-year follow-up, patients were screened for late recurrences (LRs), i.e., recurrences after the blanking period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 114 patients (85.7%), ECV was successful compared to 19 patients (14.3%) with failed ECV. A higher body mass index (odds ratio (OR) 1.19 (95% CI 1.02\u20131.39), <jats:italic>p<\/jats:italic>\u2009=\u20090.029), a lower left ventricular ejection fraction (OR 1.07 (95% CI 0.99\u20131.15), <jats:italic>p<\/jats:italic>\u2009=\u20090.079), and performance of ECV\u2009&gt;\u20097\u00a0days from ER onset (OR 2.99 (95% CI 1.01\u20138.87), <jats:italic>p<\/jats:italic>\u2009=\u20090.048) remained independently associated with ECV failure. During 1-year follow-up, the rate of LR was significantly higher among patients with failed ECV as compared to patients with successful ECV (hazard ratio (HR) 3.00 (95% CI, 1.79\u20135.03), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Patients with ECV performed\u2009&gt;\u20097\u00a0days from ER onset had a significantly higher risk of developing LR as compared to patients with ECV performed within\u2009\u2264\u20097\u00a0days from ER onset (HR 1.73 (95% CI 1.15\u20132.62), <jats:italic>p<\/jats:italic>\u2009=\u20090.009). Performance of ECV\u2009&gt;\u20097\u00a0days from ER onset (HR 1.76 (95% CI 1.16\u20132.67), <jats:italic>p<\/jats:italic>\u2009=\u20090.008) and failed ECV (HR 3.32 (95% CI 1.96\u20135.64), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) remained independently associated with LR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A failed ECV and performance of ECV\u2009&gt;\u20097\u00a0days from ER onset were independently associated with LR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10840-022-01368-w","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T14:21:53Z","timestamp":1662733313000},"page":"577-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Electrical cardioversion for early recurrences post pulmonary vein isolation"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-0414","authenticated-orcid":false,"given":"Gesa","family":"von Olshausen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Paul-Nordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Jensen-Urstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Bastani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ott","family":"Saluveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Drca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Kenneb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Saygi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Insulander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"issue":"10","key":"1368_CR1","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275\u2013444.","journal-title":"Heart Rhythm"},{"issue":"22","key":"1368_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1161\/01.CIR.100.22.2237","volume":"100","author":"MH Hsieh","year":"1999","unstructured":"Hsieh MH, Chiou CW, Wen ZC, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. Circulation. 1999;100(22):2237\u201343.","journal-title":"Circulation"},{"issue":"21","key":"1368_CR3","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"TT Issac","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1368_CR4","doi-asserted-by":"publisher","first-page":"e003909","DOI":"10.1161\/CIRCEP.115.003909","volume":"9","author":"S Willems","year":"2016","unstructured":"Willems S, Khairy P, Andrade JG, et al. Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial. Circ Arrhythm Electrophysiol. 2016;9(8):e003909.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"1368_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jce.14368","volume":"31","author":"G von Olshausen","year":"2020","unstructured":"von Olshausen G, Uijl A, Jensen-Urstad M, et al. Early recurrences of atrial tachyarrhythmias post pulmonary vein isolation. J Cardiovasc Electrophysiol. 2020;31(3):674\u201381.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"1368_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1540-8167.2010.02005.x","volume":"22","author":"G Malasana","year":"2011","unstructured":"Malasana G, Day JD, Weiss JP, et al. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(7):761\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"16","key":"1368_CR7","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1900353","volume":"380","author":"N Pluymaekers","year":"2019","unstructured":"Pluymaekers N, Dudink E, Luermans J, et al. Early or delayed cardioversion in recent-onset atrial fibrillation. N Engl J Med. 2019;380(16):1499\u2013508.","journal-title":"N Engl J Med"},{"issue":"9","key":"1368_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/europace\/eux327","volume":"20","author":"M Ebert","year":"2018","unstructured":"Ebert M, Stegmann C, Kosiuk J, et al. Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation. Europace. 2018;20(9):1428\u201334.","journal-title":"Europace"},{"issue":"5","key":"1368_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.amjcard.2018.11.039","volume":"123","author":"R Nakamaru","year":"2019","unstructured":"Nakamaru R, Tanaka N, Okada M, et al. Usefulness of failed electrical cardioversion for early recurrence after catheter ablation for atrial fibrillation as a predictor of future recurrence. Am J Cardiol. 2019;123(5):794\u2013800.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1368_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"9","key":"1368_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/jce.12423","volume":"25","author":"F Akerstrom","year":"2014","unstructured":"Akerstrom F, Bastani H, Insulander P, Schwieler J, Arias MA, Jensen-Urstad M. Comparison of regular atrial tachycardia incidence after circumferential radiofrequency versus cryoballoon pulmonary vein isolation in real-life practice. J Cardiovasc Electrophysiol. 2014;25(9):948\u201352.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"19","key":"1368_CR12","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"European Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369\u2013429.","journal-title":"Eur Heart J"},{"issue":"32","key":"1368_CR13","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","volume":"39","author":"M Rienstra","year":"2018","unstructured":"Rienstra M, Hobbelt AH, Alings M, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39(32):2987\u201396.","journal-title":"Eur Heart J"},{"issue":"3","key":"1368_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/qjmed\/hcm123","volume":"101","author":"H Soran","year":"2008","unstructured":"Soran H, Younis N, Currie P, Silas J, Jones IR, Gill G. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM. 2008;101(3):181\u20137.","journal-title":"QJM"},{"issue":"3","key":"1368_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/pace.12561","volume":"38","author":"T Gronberg","year":"2015","unstructured":"Gronberg T, Hartikainen JE, Nuotio I, et al. Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study. Pacing Clin Electrophysiol. 2015;38(3):368\u201375.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"1368_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0167-5273(01)00522-8","volume":"81","author":"C Berry","year":"2001","unstructured":"Berry C, Stewart S, Payne EM, McArthur JD, McMurray JJ. Electrical cardioversion for atrial fibrillation: outcomes in \u201creal-life\u201d clinical practice. Int J Cardiol. 2001;81(1):29\u201335.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1368_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/clc.4960240313","volume":"24","author":"M Frick","year":"2001","unstructured":"Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol. 2001;24(3):238\u201344.","journal-title":"Clin Cardiol"},{"issue":"12","key":"1368_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/j.1540-8167.2009.01553.x","volume":"20","author":"TS Baman","year":"2009","unstructured":"Baman TS, Gupta SK, Billakanty SR, et al. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome. J Cardiovasc Electrophysiol. 2009;20(12):1321\u20135.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"1368_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.amjcard.2016.11.026","volume":"119","author":"S Jaakkola","year":"2017","unstructured":"Jaakkola S, Lip GY, Biancari F, et al. Predicting unsuccessful electrical cardioversion for acute atrial fibrillation (from the AF-CVS Score). Am J Cardiol. 2017;119(5):749\u201352.","journal-title":"Am J Cardiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01368-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-022-01368-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01368-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:58:29Z","timestamp":1757095109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-022-01368-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s10840-022-01368-w","relation":{},"ISSN":["1572-8595"],"issn-type":[{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data collection was approved by the regional ethics committee and patient data were collected in accordance with the institutional ethics guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"M. J.-U. is a consultant for Johnson and Johnson and has received research grants from Medtronic. N. D. has received speaker fees from Biosense Webster and served as proctor for Biosense Webster and Medtronic. F. B. is a speaker or trial committee member for Medtronic, Biotronik, Biosense Webster, Boehringer, Pfizer, Orion, Novartis, Abbott, and Impulse Dynamics. For the remaining authors, no conflicts of interest are declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}